ResidualPlaybeta Open the radar

Medic: Pacific War

Hypnotic Ants · 2026 · $9.99 · Action · deal grade C

Measured on 2026-10-01 22:20 UTC, 4 days ago. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

  • Estimated net residual revenue: $1.2k to $1.8k per month
  • Opportunity: $1.5k per month at x1.00 dormancy
  • Estimated lifetime owners: 6.0k
  • 71% positive across 171 reviews · 17.4 reviews/month

Why it's flagged

  • Developer active, last post 0 months ago

Analyst notes (AI-assisted)

Note written 2026-09-06; the live figures above take precedence over any numbers in it.

Early-access military medical simulator set in the Pacific Theater where players diagnose and treat battlefield casualties under pressure.

Medic: Pacific War is a niche simulator with solid mechanical bones (73% positive, mixed-language player base, active dev) but faces typical early-access friction: performance bugs, incomplete content scope (one-hour main loop), and voice/art polish gaps. The low peak concurrent count (10 players in last 30 days) and dormant discount history suggest limited mainstream traction. Interesting only for a studio betting on long-tail simulator adoption or willing to fund stabilization and content expansion; not a standalone acquisition target at current state. Most realistic play: watch.

  • Risk: Multiple reports of hard-blocking bugs (inability to treat casualties, game-state resets) and poor optimization that will tank retention if not resolved before full launch.
  • Risk: Peak concurrent players in last month (10) and near-zero current players signal either extreme volatility or lack of word-of-mouth; unclear whether this is typical early-access churn or a sign of weak product-market fit.
  • Risk: Voice acting and AI-art backlash in reviews; community explicitly asks for human VO and original art, suggesting rework costs if polish is a launch requirement.

This case as Markdown · Estimates carry ±30-50% error per title.